Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer

PLoS Computational Biology

Volumn 11, Issue 12, 2015, Pages

  Ruffalo, Matthew ^a   Koyutürk, Mehmet ^a,b   Sharan, Roded ^c  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DATA INTEGRATION; DIGITAL STORAGE; DISEASES;

'OMICS'; CANCER GENOME; CANCER PROGRESSION; CELLULAR ACTIVITIES; HETEROGENEOUS DATA SOURCES; HIGH-THROUGHPUT; MOLECULAR CHANGES; MOLECULAR DATA; MONITORING TECHNOLOGIES; NETWORK-BASED;

GENE EXPRESSION;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL FUNCTION; COMPUTER SIMULATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GLIOBLASTOMA; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL COMPUTING; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; CHROMOSOMAL MAPPING; DATA MINING; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETIC MARKER; GENETICS; GENOMICS; HUMAN; NEOPLASM; PROCEDURES; SIGNAL TRANSDUCTION; SILENT MUTATION; TUMOR GENE;

GENETIC MARKER; TUMOR PROTEIN;

ALGORITHMS; CHROMOSOME MAPPING; DATA MINING; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENES, NEOPLASM; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENOMICS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; SIGNAL TRANSDUCTION; SILENT MUTATION;

EID: 84953283238     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004595     Document Type: Article

References (37)

1. Halldórsson BV, Sharan R, Network-Based Interpretation of Genomic Variation Data. Journal of Molecular Biology. 2013;425(21):3964—3969. Understanding Molecular Effects of Naturally Occurring Genetic Differences. Available from: http://www.sciencedirect.com/science/article/pii/S0022283613004737. doi: 10.1016/j.jmb.2013.07.026 23886866
2. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Research. 2011;39(suppl 1):D945–D950. Available from: http://nar.oxfordjournals.org/content/39/suppl_1/D945.abstract. doi: 10.1093/nar/gkq929 20952405
3. Erten S, Bebek G, Koyutürk M, Vavien: an algorithm for prioritizing candidate disease genes based on topological similarity of proteins in interaction networks. Journal of computational biology. 2011 Nov;18(11):1561–1574. doi: 10.1089/cmb.2011.0154 22035267
4. Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R, Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol. 2010 Jan;6(1):e1000641. doi: 10.1371/journal.pcbi.1000641 20090828
5. Hofree M, Shen JP, Carter H, Gross A, Ideker T, Network-based stratification of tumor mutations. Nature Methods. 2013 Sep;10(11):1108–1115. doi: 10.1038/nmeth.2651 24037242
6. Patel V, Gokulrangan G, Chowdhury S, Chen Y, Sloan A, Koyutürk M, et al. Network Signatures of Survival in Glioblastoma Multiforme. PLOS Computational Biology. 2013 September;9. doi: 10.1371/journal.pcbi.1003237
7. Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R, Network-based Survival Analysis Reveals Subnetwork Signatures for Predicting Outcomes of Ovarian Cancer Treatment. PLoS Comput Biol. 2013 Mar;9(3):e1002975+. doi: 10.1371/journal.pcbi.1002975 23555212
8. Vandin F, Upfal E, Raphael BJ, Algorithms for Detecting Significantly Mutated Pathways in Cancer. Journal of Computational Biology. 2011 Mar;18(3):507–522. doi: 10.1089/cmb.2010.0265 21385051
9. Ciriello G, Cerami E, Sander C, Schultz N, Mutual exclusivity analysis identifies oncogenic network modules. Genome research. 2012 Feb;22(2):398–406. doi: 10.1101/gr.125567.111 21908773
10. Kim YA, Wuchty S, Przytycka TM, Identifying Causal Genes and Dysregulated Pathways in Complex Diseases. PLoS Computational Biology. 2011;7(3). Available from: http://dblp.uni-trier.de/db/journals/ploscb/ploscb7.html#KimWP11. doi: 10.1371/journal.pcbi.1001095
11. Nibbe RK, Koyutürk M, Chance MR, An Integrative -omics Approach to Identify Functional Sub-Networks in Human Colorectal Cancer. PLoS Comput Biol. 2010 01;6(1):e1000639. doi: 10.1371/journal.pcbi.1000639 20090827
12. Huang PH, White FM, Phosphoproteomics: Unraveling the Signaling Web. Molecular Cell. 2008;31(6):777—781. Available from: http://www.sciencedirect.com/science/article/pii/S1097276508006163. doi: 10.1016/j.molcel.2008.09.001 18922462
13. The Cancer Genome AtlasComprehensive molecular portraits of human breast tumours. Nature. 2012 Oct;490(7418):61–70. doi: 10.1038/nature11412 23000897
14. Schaefer MH, Fontaine JF, Vinayagam A, Porras P, Wanker EE, Andrade-Navarro MA, HIPPIE: Integrating Protein Interaction Networks with Experiment Based Quality Scores. PLoS ONE. 2012 02;7(2):e31826. doi: 10.1371/journal.pone.0031826 22348130
15. Zhou D, Bousquet O, Lal TN, Weston J, Schölkopf B, Learning with local and global consistency. Advances in neural information processing systems. 2004;16(16):321–328.
16. Akaike H, A new look at the statistical model identification. Automatic Control, IEEE Transactions on. 1974 dec;19(6):716—723. doi: 10.1109/TAC.1974.1100705
17. Geer LY, Marchler-Bauer A, Geer RC, Han L, He J, He S, et al. The NCBI BioSystems database. Nucleic Acids Res. 2010 Jan;38(Database issue):D492–496. doi: 10.1093/nar/gkp858 19854944
18. Kanehisa M, Goto S, KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000 Jan;28(1):27–30. doi: 10.1093/nar/28.1.27 10592173
19. Deau MC, Heurtier L, Frange P, Suarez F, Bole-Feysot C, Nitschke P, et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest. 2014 Sep;124(9):3923–3928. doi: 10.1172/JCI75746 25133428
20. Di Zazzo E, Feola A, Zuchegna C, Romano A, Donini CF, Bartollino S, et al. The p85 regulatory subunit of PI3K mediates cAMP-PKA and insulin biological effects on MCF-7 cell growth and motility. ScientificWorldJournal. 2014;2014:565839. doi: 10.1155/2014/565839 25114970
21. Watanabe S, Take H, Takeda K, Yu ZX, Iwata N, Kajigaya S, Characterization of the {CIN85} Adaptor Protein and Identification of Components Involved in {CIN85} Complexes. Biochemical and Biophysical Research Communications. 2000;278(1):167–174. Available from: http://www.sciencedirect.com/science/article/pii/S0006291X00937604. doi: 10.1006/bbrc.2000.3760 11071869
22. Naramura M, Nadeau S, Mohapatra B, Ahmad G, Mukhopadhyay C, Sattler M, et al. Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders. Oncotarget. 2011 Mar;2(3):245–250. doi: 10.18632/oncotarget.233 21422499
23. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z, GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006 Dec;127(5):1041–1055. doi: 10.1016/j.cell.2006.09.048 17129787
24. Zheng W, Tayyari F, Gowda GA, Raftery D, McLamore ES, Porterfield DM, et al. Altered glucose metabolism in Harvey-ras transformed MCF10A cells. Mol Carcinog. 2015 Feb;54(2):111–120. doi: 10.1002/mc.22079 24000146
25. Kim H, Choi JA, Kim JH, Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells. J Biol Chem. 2014 Aug;289(32):22151–22160. doi: 10.1074/jbc.M114.556126 24990945
26. De Falco F, Sabatini R, Falzetti F, Di Ianni M, Sportoletti P, Baldoni S, et al. Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. Leukemia. 2015 Apr;29(4):994–998. doi: 10.1038/leu.2014.329 25425197
27. Sun W, Gaykalova DA, Ochs MF, Mambo E, Arnaoutakis D, Liu Y, et al. Activation of the NOTCH pathway in head and neck cancer. Cancer Res. 2014 Feb;74(4):1091–1104. doi: 10.1158/0008-5472.CAN-13-1259 24351288
28. Ferrando AA, The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program. 2009;p. 353–361. doi: 10.1182/asheducation-2009.1.353 20008221
29. Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S, et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica. 2012 Mar;97(3):437–441. doi: 10.3324/haematol.2011.060129 22207691
30. Croucher DR, Hochgrafe F, Zhang L, Liu L, Lyons RJ, Rickwood D, et al. Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway. Cancer Res. 2013 Mar;73(6):1969–1980. doi: 10.1158/0008-5472.CAN-12-1472 23378338
31. De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014 Sep;17(9):1156–1163. doi: 10.1038/nn.3786 25129075
32. Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer’s disease. Nat Neurosci. 2014 Sep;17(9):1164–1170. doi: 10.1038/nn.3782 25129077
33. Kobyakov DS, Avdalyan AM, Klimachev VV, Lazarev AF, Lushnikova EL, Nepomnyaschikh LM, [Non-small cell lung cancer: HER2 oncogene status]. Arkh Patol. 2015;77(2):3–9. 26027392
34. Growdon WB, Groeneweg J, Byron V, DiGloria C, Borger DR, Tambouret R, et al. HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant. Gynecol Oncol. 2015 Apr;137(1):160–166. doi: 10.1016/j.ygyno.2015.01.533 25602714
35. Jongmans MC, van der Burgt I, Hoogerbrugge PM, Noordam K, Yntema HG, Nillesen WM, et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet. 2011 Aug;19(8):870–874. doi: 10.1038/ejhg.2011.37 21407260
36. Shih HJ, Chen HH, Chen YA, Wu MH, Liou GG, Chang WW, et al. Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity. Oncotarget. 2012 Nov;3(11):1401–1415. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717801/. doi: 10.18632/oncotarget.688 23211466
37. Dikic I, Daly RJ, Signalling through the grapevine. EMBO Rep. 2012 Mar;13(3):178–180. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323131/. doi: 10.1038/embor.2012.16 22354089